Overview

The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Insulin replacement therapy may be effective in breaking the cycle of protein catabolism, undernutrition and overall clinical deterioration in pre-diabetic, insulin insufficient CF youth because of its potent anabolic effect. A significant number of CF patients might benefit from this therapeutic approach with a substantial impact on morbidity and mortality.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Collaborator:
Children's Hospitals and Clinics of Minnesota
Treatments:
Insulin
Insulin Aspart
Insulin Detemir
Insulin, Globin Zinc
Insulin, Short-Acting